Adiposity indices and dementia
- PMID: 16857578
- DOI: 10.1016/S1474-4422(06)70526-9
Adiposity indices and dementia
Abstract
Indicators of adiposity, such as body-mass index (BMI), may be markers for changes in energy metabolism that influence dementia risk, progression, and ultimately death. Cross-sectional studies show that people with dementia have a lower BMI than those without dementia, which is potentially due to a greater rate of BMI decline occurring during the years immediately preceding dementia onset. However, a high BMI can also increase the risk for dementia when measured before clinical dementia onset, which might be due to vascular disorders or bioactive hormonal compounds that are secreted by adipose tissue. In this personal view, I consider how dementia is associated with BMI by looking at the role of BMI and obesity syndromes, mechanisms associated with adiposity, and the potential for hypothalamic dysregulation during the life course. Understanding the life course of adiposity by use of common surrogate measures, such as BMI, among those who do and do not develop dementia is relevant for understanding the causes of dementia and for shaping possible treatment options.
Similar articles
-
A life course of adiposity and dementia.Eur J Pharmacol. 2008 May 6;585(1):163-75. doi: 10.1016/j.ejphar.2008.01.052. Epub 2008 Mar 4. Eur J Pharmacol. 2008. PMID: 18423446 Review.
-
Adiposity and cognitive decline: underlying mechanisms.J Alzheimers Dis. 2012;30 Suppl 2:S97-112. doi: 10.3233/JAD-2012-120487. J Alzheimers Dis. 2012. PMID: 22543853 Review.
-
Increased visceral adipose tissue rather than BMI as a risk factor for dementia.Age Ageing. 2007 Sep;36(5):488-91. doi: 10.1093/ageing/afm096. Epub 2007 Jul 26. Age Ageing. 2007. PMID: 17656423
-
37 years of body mass index and dementia: observations from the prospective population study of women in Gothenburg, Sweden.J Alzheimers Dis. 2012;28(1):163-71. doi: 10.3233/JAD-2011-110917. J Alzheimers Dis. 2012. PMID: 21965312
-
Adiposity hormones and dementia.J Neurol Sci. 2010 Dec 15;299(1-2):30-4. doi: 10.1016/j.jns.2010.08.036. Epub 2010 Sep 27. J Neurol Sci. 2010. PMID: 20875649 Review.
Cited by
-
Impact of DHA on metabolic diseases from womb to tomb.Mar Drugs. 2014 Dec 18;12(12):6190-212. doi: 10.3390/md12126190. Mar Drugs. 2014. PMID: 25528960 Free PMC article. Review.
-
Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease.Neurotox Res. 2016 Oct;30(3):295-337. doi: 10.1007/s12640-016-9643-3. Epub 2016 Jun 23. Neurotox Res. 2016. PMID: 27339162 Review.
-
Overweight in midlife is related to lower cognitive function 30 years later: a prospective study with longitudinal assessments.Dement Geriatr Cogn Disord. 2010;29(6):543-52. doi: 10.1159/000314874. Epub 2010 Jul 3. Dement Geriatr Cogn Disord. 2010. PMID: 20606436 Free PMC article.
-
VasCog 2023: 20 years of research on vascular behavioural and cognitive disorders.Cereb Circ Cogn Behav. 2024 May 6;6:100224. doi: 10.1016/j.cccb.2024.100224. eCollection 2024. Cereb Circ Cogn Behav. 2024. PMID: 38868624 Free PMC article.
-
Body mass index in midlife and dementia: Systematic review and meta-regression analysis of 589,649 men and women followed in longitudinal studies.Alzheimers Dement (Amst). 2017 Jun 20;8:165-178. doi: 10.1016/j.dadm.2017.05.007. eCollection 2017. Alzheimers Dement (Amst). 2017. PMID: 28761927 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical